QIAreach SARS-CoV-2 Antigen Test, developed in collaboration with Ellume, provides accurate and objective results in 2 to 15 minutes
Obtaining two vaccine doses remains the most effective way to ensure protection against the COVID-19 Delta variant
Fewer than one in 20 children with symptomatic COVID-19 experienced symptoms lasting longer than 4 weeks, and almost all children have fully recovered by 8 weeks
Patients with underlying heart problems are more than four times as likely to die from COVID-19
Low-cost device lets consumers check themselves for multiple strains of SARS-CoV-2 at home
Researchers have cataloged for the first time
It is hoped this therapy will be a breakthrough for patients suffering from hereditary transthyretin (ATTR) amyloidosis
Ultra-high precision off-axis paraboloids are being used to maximize power density at the focus of Petawatt laser beamlines
The Amulet is the first and only minimally invasive treatment option to offer immediate closure of the left atrial appendage, so blood-thinning medication isn't needed following implantation
The company plans to interface the algorithm into the Atellica Data Manager software in the future
Wastewater surveillance is becoming increasingly critical for community health monitoring for detecting COVID-19 outbreaks and the spread of other infectious diseases
Population genetics sequencing panel incorporates global genetic variations for superior study of disease and target discovery
The new intuitive interface provides step-by-step guidance to enhance ease of use
INTEGRA Biosciences has created a list of key steps to control laboratory resource consumption and waste production in an attempt to reduce environmental footprint
Nobelpharma will use ProBioGen’s cell-based production platform AGE1.CR.pIX to develop their lead vaccine
Project supports Croda’s global Research & Development Digital Program across all R&D locations
Molecular Cartography platform features leading microscopy and 3D imaging capabilities
Vaccine aims to combat numerous HIV strains, a key requirement of any vaccine to end the HIV/AIDs epidemic
